Evidence map›Paper›PMID 29235576›Full record

ArticleScientific reports2017

The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone.

Karin Eigner, Yüksel Filik, Florian Mark, Birgit Schütz, Günter Klambauer, Richard Moriggl, Markus Hengstschläger, Herbert Stangl, Mario Mikula, Clemens Röhrl

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Tumorous IRE1α facilitates CD8Cell communication and signaling : CCS · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Inhibition of eIF2BioMed research international · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Karin EignerCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Yüksel FilikCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Florian MarkCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Birgit SchützCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Günter KlambauerInstitute of Bioinformatics, Johannes Kepler University, Linz, Austria.
Richard MorigglLudwig Boltzmann Institute for Cancer Research, Vienna, Austria.ORCID 0000-0003-0918-9463
Markus HengstschlägerCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.
Herbert StanglCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-7288-7320
Mario MikulaCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5782-0681
Clemens RöhrlCenter for Pathobiochemistry and Genetics, Medical University of Vienna, Vienna, Austria. clemens.roehrl@meduniwien.ac.at.ORCID 0000-0002-1192-0748
Medical University of Vienna · ATJohannes Kepler University of Linz · ATUniversity of Veterinary Medicine Vienna · AT

Funding

Austrian Science Fund FWF P 25336
6 · The paper itself

Abstract

The mechanisms hallmarking melanoma progression are insufficiently understood. Here we studied the impact of the unfolded protein response (UPR) - a signalling cascade playing ambiguous roles in carcinogenesis - in melanoma malignancy. We identified isogenic patient-derived melanoma cell lines harboring BRAF

Indexed as

AnimalsAntineoplastic AgentsBiomarkers, TumorButylaminesCell Line, TumorCell MovementCell SurvivalDisease ProgressionEndoplasmic Reticulum StressFibroblast Growth FactorsGene Expression Regulation, NeoplasticHumansMelanocytesMelanomaMiceMutation4-phenylbutylamineAntineoplastic AgentsBiomarkers, TumorBRAF protein, humanButylaminesFibroblast Growth FactorsProto-Oncogene Proteins B-raf

Identifiers

PMID29235576
PMCPMC5727496
OpenAlexW2771634366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.